152.8K XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
Thomas J. Klima | See Remarks | Sale of securities on an exchange or to another person at price $ 3.92 per share. | 03 Mar 2025 | 500 | 7,878 (0%) | 0% | 3.9 | 1,960 | Common Stock |
Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.92 per share. | 03 Mar 2025 | 921 | 18,327 (0%) | 0% | 3.9 | 3,610 | Common Stock |
Richard A. Colvin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.92 per share. | 03 Mar 2025 | 584 | 7,610 (0%) | 0% | 3.9 | 2,289 | Common Stock |
Andrew Obenshain | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 763 | 19,248 (0%) | 0% | 0 | Common Stock | |
Joseph Vittiglio | Chief Business & Legal Officer | Sale of securities on an exchange or to another person at price $ 7.39 per share. | 03 Feb 2025 | 238 | 4,501 (0%) | 0% | 7.4 | 1,759 | Common Stock |
Thomas J. Klima | See Remarks | Sale of securities on an exchange or to another person at price $ 7.39 per share. | 03 Feb 2025 | 122 | 8,378 (0%) | 0% | 7.4 | 902 | Common Stock |
Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.40 per share. | 03 Feb 2025 | 86 | 18,485 (0%) | 0% | 7.4 | 636 | Common Stock |
Richard A. Colvin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.39 per share. | 03 Feb 2025 | 64 | 8,194 (0%) | 0% | 7.4 | 473 | Common Stock |
Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.24 per share. | 06 Jan 2025 | 140 | 18,571 (0%) | 0% | 9.2 | 1,294 | Common Stock |
Richard A. Colvin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 9.26 per share. | 06 Jan 2025 | 19 | 8,257 (0%) | 0% | 9.3 | 176 | Common Stock |
Colvin Richard A. | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.42 per share. | 10 Dec 2024 | 2,824 | 165,544 (0%) | 0% | 0.4 | 1,178 | Common Stock |
Obenshain Andrew | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.42 per share. | 10 Dec 2024 | 971 | 374,247 (0%) | 0% | 0.4 | 405 | Common Stock |
Nick Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 24,900 | 315,839 (0%) | 0% | 0 | Common Stock | |
Nick Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 49,850 | 49,850 | - | - | Stock Option (right to buy) | |
Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 49,850 | 49,850 | - | - | Stock Option (right to buy) | |
Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 24,900 | 49,941 (0%) | 0% | 0 | Common Stock | |
John O. Agwunobi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 49,850 | 49,850 | - | - | Stock Option (right to buy) | |
John O. Agwunobi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 24,900 | 51,364 (0%) | 0% | 0 | Common Stock | |
Richard Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 49,850 | 49,850 | - | - | Stock Option (right to buy) | |
Richard Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 24,900 | 29,563 (0%) | 0% | 0 | Common Stock | |
Elisabeth Leiderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 24,900 | 47,156 (0%) | 0% | 0 | Common Stock | |
Elisabeth Leiderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 49,850 | 49,850 | - | - | Stock Option (right to buy) | |
Najoh Tita-Reid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 24,900 | 48,160 (0%) | 0% | 0 | Common Stock | |
Najoh Tita-Reid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 49,850 | 49,850 | - | - | Stock Option (right to buy) | |
Charlotte Jones-Burton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 24,900 | 43,462 (0%) | 0% | 0 | Common Stock | |
Charlotte Jones-Burton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 49,850 | 49,850 | - | - | Stock Option (right to buy) | |
Joseph Vittiglio | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 50,000 | 94,783 (0%) | 0% | 0 | Common Stock | |
Thomas J. Klima | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 50,000 | 171,006 (0%) | 0% | 0 | Common Stock | |
Thomas J. Klima | See Remarks | Sale of securities on an exchange or to another person at price $ 0.53 per share. | 30 Sep 2024 | 1,006 | 170,000 (0%) | 0% | 0.5 | 529 | Common Stock |
O. James Sterling | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 100,000 | 100,000 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.53 per share. | 30 Sep 2024 | 34,780 | 375,218 (0%) | 0% | 0.5 | 18,270 | Common Stock |
Andrew Obenshain | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 130,000 | 409,998 (0%) | 0% | 0 | Common Stock | |
Richard A. Colvin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 50,000 | 168,368 (0%) | 0% | 0 | Common Stock | |
O. James Sterling | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 300,000 | 300,000 | - | - | Stock Options (Right to buy) | |
Thomas J. Klima | See Remarks | Sale of securities on an exchange or to another person at price $ 0.97 per share. | 03 Jun 2024 | 3,834 | 121,006 (0%) | 0% | 1.0 | 3,726 | Common Stock |
Thomas J. Klima | See Remarks | Sale of securities on an exchange or to another person at price $ 1.53 per share. | 01 Mar 2024 | 4,573 | 124,840 (0%) | 0% | 1.5 | 6,986 | Common Stock |
Thomas J. Klima | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 199,000 | 199,000 | - | - | Stock Option (right to buy) | |
Andrew Obenshain | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 650,000 | 650,000 | - | - | Stock Option (right to buy) | |
Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.53 per share. | 01 Mar 2024 | 6,095 | 279,998 (0%) | 0% | 1.5 | 9,311 | Common Stock |
Richard A. Colvin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 199,000 | 199,000 | - | - | Stock Option (right to buy) | |
Richard A. Colvin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.53 per share. | 01 Mar 2024 | 6,770 | 118,368 (0%) | 0% | 1.5 | 10,342 | Common Stock |
Christopher Krawtschuk | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 199,000 | 199,000 | - | - | Stock Option (right to buy) | |
Joseph Vittiglio | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 199,000 | 199,000 | - | - | Stock Option (right to buy) | |
Thomas J. Klima | See Remarks | Sale of securities on an exchange or to another person at price $ 0.90 per share. | 05 Feb 2024 | 2,714 | 129,413 (0%) | 0% | 0.9 | 2,449 | Common Stock |
Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.90 per share. | 05 Feb 2024 | 1,879 | 286,093 (0%) | 0% | 0.9 | 1,696 | Common Stock |
Joseph Vittiglio | Chief Business & Legal Officer | Sale of securities on an exchange or to another person at price $ 0.90 per share. | 05 Feb 2024 | 5,217 | 44,783 (0%) | 0% | 0.9 | 4,708 | Common Stock |
Richard Colvin A. | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.42 per share. | 05 Jan 2024 | 597 | 125,138 (0%) | 0% | 1.4 | 845 | Common Stock |
Obenshain Andrew | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.43 per share. | 05 Jan 2024 | 3,162 | 287,972 (0%) | 0% | 1.4 | 4,520 | Common Stock |
Christopher Krawtschuk | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.52 per share. | 06 Dec 2023 | 4,526 | 45,474 (0%) | 0% | 4.5 | 20,437 | Common Stock |
Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.54 per share. | 10 Aug 2023 | 16,929 | 291,941 (0%) | 0% | 3.5 | 59,956 | Common Stock |
Nick Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 10,790 | 290,939 (0%) | 0% | 0 | Common Stock | |
Nick Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,600 | 21,600 | - | - | Stock Option (right to buy) | |
Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,600 | 21,600 | - | - | Stock Option (right to buy) | |
Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 10,790 | 25,041 (0%) | 0% | 0 | Common Stock | |
John O. Agwunobi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 10,790 | 26,464 (0%) | 0% | 0 | Common Stock | |
John O. Agwunobi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,600 | 21,600 | - | - | Stock Option (right to buy) | |
Elisabeth Leiderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,600 | 21,600 | - | - | Stock Option (right to buy) | |
Elisabeth Leiderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 10,790 | 22,256 (0%) | 0% | 0 | Common Stock | |
Najoh Tita-Reid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 10,790 | 23,260 (0%) | 0% | 0 | Common Stock | |
Najoh Tita-Reid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,600 | 21,600 | - | - | Stock Option (right to buy) | |
Charlotte Jones-Burton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,600 | 21,600 | - | - | Stock Option (right to buy) | |
Charlotte Jones-Burton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 10,790 | 18,562 (0%) | 0% | 0 | Common Stock | |
Thomas J. Klima | See Remarks | Sale of securities on an exchange or to another person at price $ 3.50 per share. | 02 Jun 2023 | 4,130 | 133,049 (0%) | 0% | 3.5 | 14,451 | Common Stock |
Richard Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 7,500 | 7,500 | - | - | Stock Options (Right to buy) | |
Richard Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 4,663 | 4,663 (0%) | 0% | 0 | Common Stock | |
Thomas J. Klima | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 110,000 | 110,000 | - | - | Stock Option (right to buy) | |
Thomas J. Klima | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 55,000 | 137,179 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 67,600 | 308,870 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 338,000 | 338,000 | - | - | Stock Option (right to buy) | |
Richard A. Colvin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 110,000 | 110,000 | - | - | Stock Option (right to buy) | |
Richard A. Colvin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 55,000 | 128,078 (0%) | 0% | 0 | Common Stock | |
Thomas J. Klima | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.38 per share. | 01 Feb 2023 | 2,260 | 82,179 (0%) | 0% | 6.4 | 14,419 | Common Stock |
Andrew Obenshain | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.38 per share. | 01 Feb 2023 | 1,420 | 241,270 (0%) | 0% | 6.4 | 9,060 | Common Stock |
Richard A. Colvin | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.38 per share. | 01 Feb 2023 | 1,153 | 73,078 (0%) | 0% | 6.4 | 7,356 | Common Stock |
Nick Leschly | Director | Sale of securities on an exchange or to another person at price $ 7.80 per share. | 11 Jan 2023 | 4,290 | 280,149 (0%) | 0% | 7.8 | 33,480 | Common Stock |
Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.80 per share. | 11 Jan 2023 | 3,178 | 242,690 (0%) | 0% | 7.8 | 24,802 | Common Stock |
Richard A. Colvin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.80 per share. | 11 Jan 2023 | 557 | 74,231 (0%) | 0% | 7.8 | 4,347 | Common Stock |
Christopher Krawtschuk | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 100,000 | 100,000 | - | - | Stock Options (Right to buy) | |
Christopher Krawtschuk | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.41 per share. | 04 Nov 2022 | 1,263 | 245,868 (0%) | 0% | 6.4 | 8,101 | Common Stock |
Richard A. Colvin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.41 per share. | 04 Nov 2022 | 218 | 74,788 (0%) | 0% | 6.4 | 1,398 | Common Stock |
Richard A. Colvin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 60,000 | 60,000 | - | - | Stock Options (Right to buy) | |
Richard A. Colvin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 30,000 | 75,006 (0%) | 0% | 0 | Common Stock | |
Elisabeth Leiderman | Director | Sale of securities on an exchange or to another person at price $ 6.46 per share. | 17 Oct 2022 | 1,004 | 11,466 (0%) | 0% | 6.5 | 6,490 | Common Stock |
Thomas J. Klima | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 22,000 | 22,000 | - | - | Stock Option (right to buy) | |
Thomas J. Klima | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 11,000 | 82,439 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Chief Strategy & Financial Off | Sale of securities on an exchange or to another person at price $ 5.53 per share. | 19 Aug 2022 | 14,194 | 189,546 (0%) | 0% | 5.5 | 78,473 | Common Stock |
Douglas G. Cole | Chief Strategy & Financial Off | Sale of securities on an exchange or to another person at price $ 4.39 per share. | 04 Aug 2022 | 7,448 | 203,740 (0%) | 0% | 4.4 | 32,707 | Common Stock |
Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.39 per share. | 04 Aug 2022 | 21,805 | 247,131 (0%) | 0% | 4.4 | 95,754 | Common Stock |
Anne-Virginie Eggimann | Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 4.95 per share. | 12 Jul 2022 | 1,358 | 42,252 (0%) | 0% | 4.9 | 6,722 | Common Stock |
Nick Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 3,109 | 284,439 (0%) | 0% | 0 | Common Stock | |
Nick Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 4,353 | 14,251 (0%) | 0% | 0 | Common Stock | |
Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 7,000 | 7,000 | - | - | Stock Option (right to buy) | |
John O. Agwunobi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 3,109 | 15,674 (0%) | 0% | 0 | Common Stock | |
John O. Agwunobi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
Elisabeth Leiderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 3,109 | 12,470 (0%) | 0% | 0 | Common Stock | |
Elisabeth Leiderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
Najoh Tita-Reid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 3,109 | 12,470 (0%) | 0% | 0 | Common Stock | |
Najoh Tita-Reid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
Charlotte Jones-Burton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 3,109 | 7,772 (0%) | 0% | 0 | Common Stock | |
Charlotte Jones-Burton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
Thomas J. Klima | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 3.07 per share. | 03 Jun 2022 | 3,753 | 71,439 (0%) | 0% | 3.1 | 11,535 | Common Stock |
Charlotte Jones-Burton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 7,500 | 7,500 | - | - | Stock Options (Right to buy) | |
Charlotte Jones-Burton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 4,663 | 4,663 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 25,000 | 211,188 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
Gina Consylman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 25,000 | 125,385 (0%) | 0% | 0 | Common Stock | |
Gina Consylman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
Thomas J. Klima | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
Thomas J. Klima | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 25,000 | 75,192 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 18,000 | 268,936 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
Anne-Virginie Eggimann | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 34,000 | 34,000 | - | - | Stock Option (right to buy) | |
Anne-Virginie Eggimann | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 17,000 | 43,610 (0%) | 0% | 0 | Common Stock | |
Jessica Whitten | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
Jessica Whitten | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 7,500 | 56,913 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 9.40 per share. | 10 Jan 2022 | 1,584 | 189,575 (0%) | 0% | 9.4 | 14,893 | Common Stock |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 9.64 per share. | 10 Jan 2022 | 3,387 | 186,188 (0%) | 0% | 9.6 | 32,659 | Common Stock |
Nick Leschly | Director | Sale of securities on an exchange or to another person at price $ 9.64 per share. | 10 Jan 2022 | 5,068 | 281,330 (0%) | 0% | 9.6 | 48,869 | Common Stock |
Nick Leschly | Director | Sale of securities on an exchange or to another person at price $ 9.40 per share. | 10 Jan 2022 | 2,369 | 286,398 (0%) | 0% | 9.4 | 22,274 | Common Stock |
Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.40 per share. | 10 Jan 2022 | 2,190 | 251,379 (0%) | 0% | 9.4 | 20,591 | Common Stock |
Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.64 per share. | 10 Jan 2022 | 4,683 | 246,696 (0%) | 0% | 9.6 | 45,156 | Common Stock |
Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.24 per share. | 10 Jan 2022 | 852 | 253,569 (0%) | 0% | 9.2 | 7,876 | Common Stock |
Jessica Whitten | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 9.64 per share. | 10 Jan 2022 | 279 | 49,413 (0%) | 0% | 9.6 | 2,690 | Common Stock |
Jessica Whitten | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 9.40 per share. | 10 Jan 2022 | 130 | 49,692 (0%) | 0% | 9.4 | 1,222 | Common Stock |
Jessica Whitten | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 10.44 per share. | 05 Jan 2022 | 2,984 | 49,822 (0%) | 0% | 10.4 | 31,143 | Common Stock |
Jessica Whitten | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 9,502 | 52,806 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.18 per share. | 07 Dec 2021 | 832 | 254,421 (0%) | 0% | 10.2 | 8,469 | Common Stock |
Douglas G. Cole | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 27,606 | 61,599 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 6,645 | 33,993 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 64,779 | 191,159 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 64,781 | 126,380 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 1,539 | 24,271 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 3,077 | 27,348 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 27,500 | 55,211 | - | - | Stock Option (right to buy) | |
Douglas G. Cole | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 18,000 | 17,721 | - | - | Stock Option (right to buy) | |
Douglas G. Cole | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 25,000 | 24,613 | - | - | Stock Option (right to buy) | |
Douglas G. Cole | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 25,000 | 24,613 | - | - | Stock Option (right to buy) | |
Douglas G. Cole | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 28,500 | 28,059 | - | - | Stock Option (right to buy) | |
Douglas G. Cole | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 8,938 | 8,799 | - | - | Stock Option (right to buy) | |
Douglas G. Cole | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 35,000 | 34,458 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 2,092 | 23,420 (0%) | 0% | 0 | Common Stock | |
Philip D. Gregory | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 20,000 | 19,690 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 27,000 | 26,582 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 34,000 | 33,474 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 25,000 | 24,613 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 6,200 | 6,103 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 50,000 | 49,227 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,384 | 34,127 (0%) | 0% | 0 | Common Stock | |
Philip D. Gregory | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 3,323 | 26,743 (0%) | 0% | 0 | Common Stock | |
Wendy L. Dixon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 3,000 | 2,953 | - | - | Stock Option (right to buy) | |
Wendy L. Dixon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 6,241 | 11,894 (0%) | 0% | 0 | Common Stock | |
Wendy L. Dixon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 26,361 | 25,953 | - | - | Stock Option (right to buy) | |
Wendy L. Dixon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,500 | 7,384 | - | - | Stock Option (right to buy) | |
Wendy L. Dixon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 4,000 | 3,938 | - | - | Stock Option (right to buy) | |
Wendy L. Dixon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 5,000 | 10,038 | - | - | Stock Option (right to buy) | |
Wendy L. Dixon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,500 | 7,384 | - | - | Stock Option (right to buy) | |
Wendy L. Dixon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 4,000 | 3,938 | - | - | Stock Option (right to buy) | |
Wendy L. Dixon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 4,000 | 3,938 | - | - | Stock Option (right to buy) | |
Wendy L. Dixon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 4,000 | 3,938 | - | - | Stock Option (right to buy) | |
Gina Consylman | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 170,655 | 170,655 | - | - | Stock Option (right to buy) | |
Gina Consylman | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 100,385 | 100,385 (0%) | 0% | 0 | Common Stock | |
William D. Baird | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 20,000 | 19,690 | - | - | Stock Option (right to buy) | |
William D. Baird | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
William D. Baird | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 60,000 | 59,072 | - | - | Stock Option (right to buy) | |
William D. Baird | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,384 | 22,797 (0%) | 0% | 0 | Common Stock | |
William D. Baird | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,384 | 15,413 (0%) | 0% | 0 | Common Stock | |
Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 120,000 | 118,145 | - | - | Stock Option (right to buy) | |
Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 100,000 | 98,454 | - | - | Common Stock | |
Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 65,000 | 63,995 | - | - | Stock Option (right to buy) | |
Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 90,000 | 0 | - | - | Stock Option (right to buy) | |
Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 110,000 | 108,300 | - | - | Stock Option (right to buy) | |
Nick Leschly | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 23,998 | 288,005 (0%) | 0% | 0 | Common Stock | |
Nick Leschly | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 12,306 | 264,007 (0%) | 0% | 0 | Common Stock | |
Nick Leschly | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,384 | 251,701 (0%) | 0% | 0 | Common Stock | |
Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 165,000 | 162,450 | - | - | Stock Option (right to buy) | |
Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 90,000 | 88,609 | - | - | Stock Option (right to buy) | |
Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 165,000 | 162,450 | - | - | Stock Option (right to buy) | |
Daniel S. Lynch | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 10,500 | 10,337 | - | - | Stock Option (right to buy) | |
Daniel S. Lynch | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 10,500 | 10,337 | - | - | Stock Option (right to buy) | |
Daniel S. Lynch | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 5,600 | 5,513 | - | - | Stock Option (right to buy) | |
Daniel S. Lynch | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 5,600 | 5,513 | - | - | Stock Option (right to buy) | |
Daniel S. Lynch | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 5,600 | 5,513 | - | - | Stock Option (right to buy) | |
Daniel S. Lynch | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 5,600 | 5,513 | - | - | Stock Option (right to buy) | |
Daniel S. Lynch | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 4,200 | 4,135 | - | - | Stock Option (right to buy) | |
Daniel S. Lynch | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,000 | 0 | - | - | Stock Option (right to buy) | |
Daniel S. Lynch | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 23,342 | 22,981 | - | - | Stock Option (right to buy) | |
Mark Vachon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 3,938 | 3,938 | - | - | Stock Option (right to buy) | |
Mark Vachon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 3,938 | 3,938 | - | - | Stock Option (right to buy) | |
Mark Vachon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,384 | 7,384 | - | - | Stock Option (right to buy) | |
Mark Vachon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 6,241 | 9,898 (0%) | 0% | 0 | Common Stock | |
Mark Vachon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 10,038 | 10,038 | - | - | Stock Option (right to buy) | |
Mark Vachon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 2,953 | 2,953 | - | - | Stock Option (right to buy) | |
Mark Vachon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 3,938 | 3,938 | - | - | Stock Option (right to buy) | |
John O. Agwunobi | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 10,534 | 10,534 | - | - | Stock Option (right to buy) | |
John O. Agwunobi | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 6,241 | 12,565 (0%) | 0% | 0 | Common Stock | |
John O. Agwunobi | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 10,038 | 10,038 | - | - | Stock Option (right to buy) | |
John O. Agwunobi | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 3,938 | 3,938 | - | - | Stock Option (right to buy) | |
John O. Agwunobi | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 3,938 | 3,938 | - | - | Stock Option (right to buy) | |
John O. Agwunobi | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 3,938 | 3,938 | - | - | Stock Option (right to buy) | |
Thomas J. Klima | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 100,385 | 100,385 | - | - | Stock Option (right to buy) | |
Thomas J. Klima | Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 50,192 | 50,192 (0%) | 0% | 0 | Common Stock | |
Sarah Glickman | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,500 | 0 | - | - | Stock Option (right to buy) | |
William R. Sellers | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 657 | 3,601 (0%) | 0% | 0 | Common Stock | |
William R. Sellers | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 8,000 | 7,876 | - | - | Stock Option (right to buy) | |
William R. Sellers | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 3,000 | 2,953 | - | - | Stock Option (right to buy) | |
William R. Sellers | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 5,000 | 0 | - | - | Stock Option (right to buy) | |
Ramy Ibrahim | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 4,500 | 0 | - | - | Stock Option (right to buy) | |
Ramy Ibrahim | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 5,000 | 0 | - | - | Stock Option (right to buy) | |
Denice M. Torres | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 5,000 | 0 | - | - | Stock Option (right to buy) | |
Denice M. Torres | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 4,500 | 4,430 | - | - | Stock Option (right to buy) | |
Denice M. Torres | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 1,476 | 2,726 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 10,337 | 24,367 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 586 | 10,468 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 978 | 11,446 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 2,584 | 14,030 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 30,115 | 54,482 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 200,771 | 255,253 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 18,000 | 17,721 | - | - | Stock Option (right to buy) | |
Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 9,500 | 9,353 | - | - | Stock Option (right to buy) | |
Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,950 | 7,827 | - | - | Stock Option (right to buy) | |
Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,000 | 6,891 | - | - | Stock Option (right to buy) | |
Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 21,000 | 20,674 | - | - | Stock Option (right to buy) | |
Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 30,000 | 60,230 | - | - | Stock Option (right to buy) | |
Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 200,000 | 401,543 | - | - | Stock Option (right to buy) | |
Elisabeth Leiderman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 15,057 | 15,057 | - | - | Stock Option (right to buy) | |
Elisabeth Leiderman | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 9,361 | 9,361 (0%) | 0% | 0 | Common Stock | |
Marcela V. Maus | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,500 | 0 | - | - | Stock Option (right to buy) | |
Najoh Tita-Reid | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 15,057 | 15,057 | - | - | Stock Option (right to buy) | |
Najoh Tita-Reid | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 9,361 | 9,361 (0%) | 0% | 0 | Common Stock | |
Jessica Whitten | Chief Accounting Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 8,030 | 8,030 | - | - | Stock Option (right to buy) | |
Jessica Whitten | Chief Accounting Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 1,459 | 2,358 (0%) | 0% | 0 | Common Stock | |
Jessica Whitten | Chief Accounting Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 4,015 | 6,373 (0%) | 0% | 0 | Common Stock | |
Jessica Whitten | Chief Accounting Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 36,931 | 43,304 (0%) | 0% | 0 | Common Stock | |
Jessica Whitten | Chief Accounting Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,776 | 7,776 | - | - | Stock Option (right to buy) | |
Elisabeth Leiderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
Elisabeth Leiderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 4,663 | 4,663 (0%) | 0% | 0 | Common Stock | |
Najoh Tita-Reid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2021 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
Najoh Tita-Reid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2021 | 4,663 | 4,663 (0%) | 0% | 0 | Common Stock | |
Marcela V. Maus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2021 | 4,663 | 4,663 (0%) | 0% | 0 | Common Stock | |
Marcela V. Maus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2021 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
Douglas G. Cole | Chief Operating and, Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 32,265 | 112,453 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Chief Operating and, Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 32,266 | 80,188 (0%) | 0% | 0 | Common Stock | |
Philip D. Gregory | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 33,926 | 114,682 (0%) | 0% | 0 | Common Stock | |
Philip D. Gregory | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 33,927 | 80,756 (0%) | 0% | 0 | Common Stock | |
William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 33,585 | 69,114 (0%) | 0% | 0 | Common Stock | |
William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 33,584 | 102,698 (0%) | 0% | 0 | Common Stock | |
Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 51,303 | 409,299 (0%) | 0% | 0 | Common Stock | |
Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 51,304 | 357,996 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | President of SGD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 100,000 | 139,597 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | President of SGD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 3,109 | 8,762 (0%) | 0% | 0 | Common Stock | |
Daniel S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 4,353 | 12,312 (0%) | 0% | 0 | Common Stock | |
Daniel S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 7,000 | 7,000 | - | - | Stock Option (right to buy) | |
Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 3,109 | 6,766 (0%) | 0% | 0 | Common Stock | |
Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
John O. Agwunobi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 3,109 | 9,433 (0%) | 0% | 0 | Common Stock | |
John O. Agwunobi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
William R. Sellers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
William R. Sellers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 3,109 | 6,721 (0%) | 0% | 0 | Common Stock | |
Ramy Ibrahim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
Ramy Ibrahim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 3,109 | 5,359 (0%) | 0% | 0 | Common Stock | |
Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 3,109 | 5,859 (0%) | 0% | 0 | Common Stock | |
Denice M. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
Andrew Obenshain | President of SGD | Sale of securities on an exchange or to another person at price $ 30.75 per share. | 04 Jun 2021 | 511 | 39,597 (0%) | 0% | 30.8 | 15,715 | Common Stock |
Thomas J. Klima | Chief Commercial Officer, SGD | Grant, award, or other acquisition of securities at price $ 31.11 per share. | 01 Jun 2021 | 25,000 | 25,000 (0%) | 0% | 31.1 | 777,750 | Common Stock |
Thomas J. Klima | Chief Commercial Officer, SGD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
Nick Leschly | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 May 2021 | 123,000 | 123,000 (0%) | 0% | 0 | Common Stock | |
Nick Leschly | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 May 2021 | 123,000 | 45,699 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 30.16 per share. | 03 May 2021 | 38 | 47,922 (0%) | 0% | 30.2 | 1,146 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 30.15 per share. | 03 May 2021 | 39 | 46,829 (0%) | 0% | 30.2 | 1,176 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 30.15 per share. | 03 May 2021 | 444 | 306,692 (0%) | 0% | 30.2 | 13,387 | Common Stock |
Andrew Obenshain | President of SGD | Sale of securities on an exchange or to another person at price $ 30.14 per share. | 03 May 2021 | 29 | 40,108 (0%) | 0% | 30.1 | 874 | Common Stock |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 30.22 per share. | 05 Apr 2021 | 37 | 47,960 (0%) | 0% | 30.2 | 1,118 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 30.21 per share. | 05 Apr 2021 | 39 | 46,868 (0%) | 0% | 30.2 | 1,178 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 30.20 per share. | 05 Apr 2021 | 444 | 307,136 (0%) | 0% | 30.2 | 13,411 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.21 per share. | 05 Apr 2021 | 42 | 47,787 (0%) | 0% | 30.2 | 1,269 | Common Stock |
Andrew Obenshain | President of SGD | Sale of securities on an exchange or to another person at price $ 30.21 per share. | 05 Apr 2021 | 29 | 40,137 (0%) | 0% | 30.2 | 876 | Common Stock |
Nick Leschly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2021 | 203,355 | 0 | - | - | Stock Option (right to buy) | |
Nick Leschly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 04 Mar 2021 | 203,355 | 307,580 (0%) | 0% | 5.5 | 1,118,534 | Common Stock |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 29.58 per share. | 02 Mar 2021 | 38 | 47,997 (0%) | 0% | 29.6 | 1,124 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 29.59 per share. | 02 Mar 2021 | 39 | 46,907 (0%) | 0% | 29.6 | 1,154 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 29.58 per share. | 02 Mar 2021 | 444 | 104,225 (0%) | 0% | 29.6 | 13,134 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 29.57 per share. | 02 Mar 2021 | 42 | 47,829 (0%) | 0% | 29.6 | 1,242 | Common Stock |
Andrew Obenshain | President of SGD | Sale of securities on an exchange or to another person at price $ 29.59 per share. | 02 Mar 2021 | 34 | 40,166 (0%) | 0% | 29.6 | 1,006 | Common Stock |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 28.16 per share. | 16 Feb 2021 | 665 | 48,035 (0%) | 0% | 28.2 | 18,727 | Common Stock |
Douglas G. Cole | Chief Operating and, Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 2,165 | 48,700 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Chief Operating and, Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 13,750 | 46,535 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Chief Operating and, Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 27,500 | 27,500 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 2,162 | 47,610 (0%) | 0% | 0 | Common Stock | |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.16 per share. | 16 Feb 2021 | 664 | 46,946 (0%) | 0% | 28.2 | 18,699 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 12,500 | 45,448 (0%) | 0% | 0 | Common Stock | |
William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 28.16 per share. | 16 Feb 2021 | 693 | 35,529 (0%) | 0% | 28.2 | 19,516 | Common Stock |
William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 2,141 | 36,222 (0%) | 0% | 0 | Common Stock | |
William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 12,500 | 34,081 (0%) | 0% | 0 | Common Stock | |
William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 25,000 | 25,000 | - | - | Stock Options (Right to buy) | |
Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 18,000 | 104,669 (0%) | 0% | 0 | Common Stock | |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.16 per share. | 16 Feb 2021 | 698 | 47,871 (0%) | 0% | 28.2 | 19,657 | Common Stock |
David Davidson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 2,271 | 48,569 (0%) | 0% | 0 | Common Stock | |
David Davidson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 10,000 | 46,298 (0%) | 0% | 0 | Common Stock | |
David Davidson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Katy Burnett | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 1,427 | 4,615 (0%) | 0% | 0 | Common Stock | |
Katy Burnett | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 28.16 per share. | 16 Feb 2021 | 518 | 4,097 (0%) | 0% | 28.2 | 14,588 | Common Stock |
Katy Burnett | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 2,000 | 3,188 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | President of SGD | Sale of securities on an exchange or to another person at price $ 28.16 per share. | 16 Feb 2021 | 749 | 40,200 (0%) | 0% | 28.2 | 21,093 | Common Stock |
Andrew Obenshain | President of SGD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
Andrew Obenshain | President of SGD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 2,065 | 40,949 (0%) | 0% | 0 | Common Stock | |
Andrew Obenshain | President of SGD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 15,000 | 38,884 (0%) | 0% | 0 | Common Stock | |
William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 45.52 per share. | 12 Feb 2021 | 1,216 | 21,581 (0%) | 0% | 45.5 | 55,352 | Common Stock |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 45.92 per share. | 02 Feb 2021 | 38 | 32,785 (0%) | 0% | 45.9 | 1,745 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 45.93 per share. | 02 Feb 2021 | 59 | 32,948 (0%) | 0% | 45.9 | 2,710 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 45.93 per share. | 02 Feb 2021 | 594 | 86,669 (0%) | 0% | 45.9 | 27,280 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 45.92 per share. | 02 Feb 2021 | 63 | 36,298 (0%) | 0% | 45.9 | 2,893 | Common Stock |
Andrew Obenshain | President of SGD | Sale of securities on an exchange or to another person at price $ 45.91 per share. | 02 Feb 2021 | 34 | 23,884 (0%) | 0% | 45.9 | 1,561 | Common Stock |
Ramy Ibrahim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 2,250 | 2,250 (0%) | 0% | 0 | Common Stock | |
Ramy Ibrahim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 4,500 | 4,500 | - | - | Stock Options (Right to buy) | |
William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 45.46 per share. | 06 Jan 2021 | 397 | 22,797 (0%) | 0% | 45.5 | 18,049 | Common Stock |
William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 44.76 per share. | 06 Jan 2021 | 552 | 23,194 (0%) | 0% | 44.8 | 24,707 | Common Stock |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 44.95 per share. | 05 Jan 2021 | 43 | 35,181 (0%) | 0% | 45.0 | 1,933 | Common Stock |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 45.46 per share. | 05 Jan 2021 | 986 | 32,823 (0%) | 0% | 45.5 | 44,827 | Common Stock |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 44.76 per share. | 05 Jan 2021 | 1,372 | 33,809 (0%) | 0% | 44.8 | 61,409 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 44.76 per share. | 05 Jan 2021 | 1,602 | 34,159 (0%) | 0% | 44.8 | 71,703 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 44.96 per share. | 05 Jan 2021 | 45 | 35,761 (0%) | 0% | 45.0 | 2,023 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 45.46 per share. | 05 Jan 2021 | 1,152 | 33,007 (0%) | 0% | 45.5 | 52,374 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 44.95 per share. | 05 Jan 2021 | 333 | 97,358 (0%) | 0% | 45.0 | 14,969 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 44.76 per share. | 05 Jan 2021 | 5,873 | 91,485 (0%) | 0% | 44.8 | 262,867 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 45.46 per share. | 05 Jan 2021 | 4,222 | 87,263 (0%) | 0% | 45.5 | 191,947 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 44.76 per share. | 05 Jan 2021 | 1,843 | 37,685 (0%) | 0% | 44.8 | 82,490 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 44.96 per share. | 05 Jan 2021 | 48 | 39,528 (0%) | 0% | 45.0 | 2,158 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 45.46 per share. | 05 Jan 2021 | 1,324 | 36,361 (0%) | 0% | 45.5 | 60,194 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 44.95 per share. | 05 Jan 2021 | 40 | 26,917 (0%) | 0% | 45.0 | 1,798 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 45.46 per share. | 05 Jan 2021 | 759 | 25,103 (0%) | 0% | 45.5 | 34,507 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 44.76 per share. | 05 Jan 2021 | 1,055 | 25,862 (0%) | 0% | 44.8 | 47,220 | Common Stock |
Katy Burnett | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 46.09 per share. | 03 Dec 2020 | 123 | 1,460 (0%) | 0% | 46.1 | 5,669 | Common Stock |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 46.19 per share. | 02 Dec 2020 | 37 | 35,225 (0%) | 0% | 46.2 | 1,709 | Common Stock |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 47.00 per share. | 02 Dec 2020 | 1 | 35,224 (0%) | 0% | 47 | 47 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 46.50 per share. | 02 Dec 2020 | 2 | 35,806 (0%) | 0% | 46.5 | 93 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 46.19 per share. | 02 Dec 2020 | 57 | 35,808 (0%) | 0% | 46.2 | 2,633 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 46.19 per share. | 02 Dec 2020 | 430 | 97,705 (0%) | 0% | 46.2 | 19,861 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 46.50 per share. | 02 Dec 2020 | 14 | 97,691 (0%) | 0% | 46.5 | 651 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 46.50 per share. | 02 Dec 2020 | 2 | 39,576 (0%) | 0% | 46.5 | 93 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 46.19 per share. | 02 Dec 2020 | 62 | 39,578 (0%) | 0% | 46.2 | 2,864 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 46.20 per share. | 02 Dec 2020 | 35 | 26,958 (0%) | 0% | 46.2 | 1,617 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 47.00 per share. | 02 Dec 2020 | 1 | 26,957 (0%) | 0% | 47 | 47 | Common Stock |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 53.86 per share. | 02 Nov 2020 | 7 | 35,266 (0%) | 0% | 53.9 | 377 | Common Stock |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 54.50 per share. | 02 Nov 2020 | 4 | 35,262 (0%) | 0% | 54.5 | 218 | Common Stock |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 52.50 per share. | 02 Nov 2020 | 26 | 35,273 (0%) | 0% | 52.5 | 1,365 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 52.51 per share. | 02 Nov 2020 | 43 | 35,881 (0%) | 0% | 52.5 | 2,258 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 54.50 per share. | 02 Nov 2020 | 6 | 35,865 (0%) | 0% | 54.5 | 327 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 53.80 per share. | 02 Nov 2020 | 10 | 35,871 (0%) | 0% | 53.8 | 538 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 54.44 per share. | 02 Nov 2020 | 45 | 98,135 (0%) | 0% | 54.4 | 2,450 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 52.51 per share. | 02 Nov 2020 | 319 | 98,260 (0%) | 0% | 52.5 | 16,750 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 53.82 per share. | 02 Nov 2020 | 80 | 98,180 (0%) | 0% | 53.8 | 4,306 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 54.50 per share. | 02 Nov 2020 | 6 | 39,640 (0%) | 0% | 54.5 | 327 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 53.83 per share. | 02 Nov 2020 | 12 | 39,646 (0%) | 0% | 53.8 | 646 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 52.51 per share. | 02 Nov 2020 | 45 | 39,658 (0%) | 0% | 52.5 | 2,363 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 54.50 per share. | 02 Nov 2020 | 4 | 26,993 (0%) | 0% | 54.5 | 218 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 52.50 per share. | 02 Nov 2020 | 24 | 27,004 (0%) | 0% | 52.5 | 1,260 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 53.86 per share. | 02 Nov 2020 | 7 | 26,997 (0%) | 0% | 53.9 | 377 | Common Stock |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 52.76 per share. | 02 Oct 2020 | 38 | 35,299 (0%) | 0% | 52.8 | 2,005 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 52.77 per share. | 02 Oct 2020 | 60 | 35,924 (0%) | 0% | 52.8 | 3,166 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 52.76 per share. | 02 Oct 2020 | 450 | 98,579 (0%) | 0% | 52.8 | 23,744 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 52.77 per share. | 02 Oct 2020 | 64 | 39,703 (0%) | 0% | 52.8 | 3,377 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 52.78 per share. | 02 Oct 2020 | 36 | 27,028 (0%) | 0% | 52.8 | 1,900 | Common Stock |
Douglas G. Cole | Chief Operating and, Legal Officer | Sale of securities on an exchange or to another person at price $ 58.61 per share. | 03 Sep 2020 | 36 | 35,337 (0%) | 0% | 58.6 | 2,110 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 58.60 per share. | 03 Sep 2020 | 58 | 35,984 (0%) | 0% | 58.6 | 3,399 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 58.60 per share. | 03 Sep 2020 | 431 | 99,029 (0%) | 0% | 58.6 | 25,257 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 58.61 per share. | 03 Sep 2020 | 41 | 39,767 (0%) | 0% | 58.6 | 2,403 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 58.60 per share. | 03 Sep 2020 | 35 | 27,063 (0%) | 0% | 58.6 | 2,051 | Common Stock |
Denice Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2020 | 4,500 | 4,500 | - | - | Stock Option (right to buy) | |
Denice Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2020 | 2,250 | 2,750 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Other, Legal Officer | Sale of securities on an exchange or to another person at price $ 60.32 per share. | 03 Aug 2020 | 28 | 35,382 (0%) | 0% | 60.3 | 1,689 | Common Stock |
Douglas G. Cole | Other, Legal Officer | Sale of securities on an exchange or to another person at price $ 61.00 per share. | 03 Aug 2020 | 9 | 35,373 (0%) | 0% | 61 | 549 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 61.00 per share. | 03 Aug 2020 | 15 | 36,042 (0%) | 0% | 61 | 915 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 60.32 per share. | 03 Aug 2020 | 44 | 36,057 (0%) | 0% | 60.3 | 2,654 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 60.32 per share. | 03 Aug 2020 | 332 | 99,572 (0%) | 0% | 60.3 | 20,026 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 60.98 per share. | 03 Aug 2020 | 112 | 99,460 (0%) | 0% | 61.0 | 6,830 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 62.00 per share. | 03 Aug 2020 | 11 | 39,808 (0%) | 0% | 62 | 682 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 60.32 per share. | 03 Aug 2020 | 31 | 39,819 (0%) | 0% | 60.3 | 1,870 | Common Stock |
Kory J. Wentworth | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 61.00 per share. | 03 Aug 2020 | 82 | 9,512 (0%) | 0% | 61 | 5,002 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 61.00 per share. | 03 Aug 2020 | 9 | 27,098 (0%) | 0% | 61 | 549 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 60.31 per share. | 03 Aug 2020 | 26 | 27,107 (0%) | 0% | 60.3 | 1,568 | Common Stock |
Kory J. Wentworth | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 66.38 per share. | 20 Jul 2020 | 596 | 9,594 (0%) | 0% | 66.4 | 39,562 | Common Stock |
Douglas G. Cole | Other, Legal Officer | Sale of securities on an exchange or to another person at price $ 61.58 per share. | 02 Jul 2020 | 38 | 35,410 (0%) | 0% | 61.6 | 2,340 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 61.58 per share. | 02 Jul 2020 | 59 | 36,101 (0%) | 0% | 61.6 | 3,633 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 61.57 per share. | 02 Jul 2020 | 443 | 99,904 (0%) | 0% | 61.6 | 27,277 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 61.57 per share. | 02 Jul 2020 | 42 | 39,850 (0%) | 0% | 61.6 | 2,586 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 61.58 per share. | 02 Jul 2020 | 36 | 27,133 (0%) | 0% | 61.6 | 2,217 | Common Stock |
Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 3,000 | 3,000 | - | - | Stock Option (right to buy) | |
Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 153 | 4,153 (0%) | 0% | 0 | Common Stock | |
Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 1,500 | 5,653 (0%) | 0% | 0 | Common Stock | |
Douglas A. Melton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 3,000 | 3,000 | - | - | Stock Option (right to buy) | |
Douglas A. Melton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 1,500 | 6,324 (0%) | 0% | 0 | Common Stock | |
Douglas A. Melton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 124 | 4,824 (0%) | 0% | 0 | Common Stock | |
Daniel S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 4,200 | 4,200 | - | - | Stock Option (right to buy) | |
Daniel S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 2,100 | 7,959 (0%) | 0% | 0 | Common Stock | |
Daniel S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 259 | 5,859 (0%) | 0% | 0 | Common Stock | |
David P. Schenkein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 1,500 | 6,832 (0%) | 0% | 0 | Common Stock | |
David P. Schenkein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 156 | 5,332 (0%) | 0% | 0 | Common Stock | |
David P. Schenkein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 3,000 | 3,000 | - | - | Stock Option (right to buy) | |
Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 157 | 2,157 (0%) | 0% | 0 | Common Stock | |
Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 1,500 | 3,657 (0%) | 0% | 0 | Common Stock | |
Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 3,000 | 3,000 | - | - | Stock Option (right to buy) | |
John O. Agwunobi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 1,500 | 6,324 (0%) | 0% | 0 | Common Stock | |
John O. Agwunobi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 3,000 | 3,000 | - | - | Stock Option (right to buy) | |
John O. Agwunobi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 124 | 4,824 (0%) | 0% | 0 | Common Stock | |
William R. Sellers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 3,000 | 3,000 | - | - | Stock Option (right to buy) | |
William R. Sellers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 1,500 | 3,612 (0%) | 0% | 0 | Common Stock | |
William R. Sellers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 112 | 2,112 (0%) | 0% | 0 | Common Stock | |
Kory J. Wentworth | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 65.56 per share. | 04 Jun 2020 | 62 | 10,190 (0%) | 0% | 65.6 | 4,065 | Common Stock |
Kory J. Wentworth | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 65.01 per share. | 04 Jun 2020 | 92 | 10,252 (0%) | 0% | 65.0 | 5,981 | Common Stock |
Douglas G. Cole | Other, Legal Officer | Sale of securities on an exchange or to another person at price $ 64.24 per share. | 02 Jun 2020 | 29 | 35,448 (0%) | 0% | 64.2 | 1,863 | Common Stock |
Douglas G. Cole | Other, Legal Officer | Sale of securities on an exchange or to another person at price $ 63.33 per share. | 02 Jun 2020 | 9 | 35,477 (0%) | 0% | 63.3 | 570 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 64.24 per share. | 02 Jun 2020 | 45 | 36,160 (0%) | 0% | 64.2 | 2,891 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 63.36 per share. | 02 Jun 2020 | 14 | 36,205 (0%) | 0% | 63.4 | 887 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 64.24 per share. | 02 Jun 2020 | 341 | 100,347 (0%) | 0% | 64.2 | 21,907 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 63.36 per share. | 02 Jun 2020 | 103 | 100,688 (0%) | 0% | 63.4 | 6,526 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 63.40 per share. | 02 Jun 2020 | 10 | 39,924 (0%) | 0% | 63.4 | 634 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 64.25 per share. | 02 Jun 2020 | 32 | 39,892 (0%) | 0% | 64.3 | 2,056 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 64.26 per share. | 02 Jun 2020 | 27 | 27,169 (0%) | 0% | 64.3 | 1,735 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 63.38 per share. | 02 Jun 2020 | 8 | 27,196 (0%) | 0% | 63.4 | 507 | Common Stock |
Douglas G. Cole | Other, Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2020 | 1,437 | 35,486 (0%) | 0% | 0 | Common Stock | |
Philip D. Gregory | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2020 | 1,511 | 36,219 (0%) | 0% | 0 | Common Stock | |
Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2020 | 11,384 | 100,791 (0%) | 0% | 0 | Common Stock | |
David Davidson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2020 | 1,615 | 39,934 (0%) | 0% | 0 | Common Stock | |
Alison Cecily Finger | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2020 | 1,361 | 27,204 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Other, Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 9,000 | 34,049 (0%) | 0% | 0 | Common Stock | |
Douglas G. Cole | Other, Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 10,000 | 34,708 (0%) | 0% | 0 | Common Stock | |
Philip D. Gregory | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 10,000 | 23,746 (0%) | 0% | 0 | Common Stock | |
Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 32,500 | 89,407 (0%) | 0% | 0 | Common Stock | |
David Davidson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
David Davidson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 10,000 | 38,319 (0%) | 0% | 0 | Common Stock | |
Kory J. Wentworth | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 3,900 | 10,344 (0%) | 0% | 0 | Common Stock | |
Kory J. Wentworth | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 7,800 | 7,800 | - | - | Stock Option (right to buy) | |
Alison Cecily Finger | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
Alison Cecily Finger | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 7,500 | 25,843 (0%) | 0% | 0 | Common Stock | |
William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 90.60 per share. | 13 Feb 2020 | 1,254 | 13,746 (0%) | 0% | 90.6 | 113,612 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. | 10 Jan 2020 | 600 | 25,308 (0%) | 0% | 50.5 | 30,306 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2020 | 600 | 6,200 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 94.03 per share. | 10 Jan 2020 | 600 | 24,708 (0%) | 0% | 94.0 | 56,416 | Common Stock |
Douglas G. Cole | Other, Legal Officer | Sale of securities on an exchange or to another person at price $ 89.97 per share. | 07 Jan 2020 | 1,957 | 25,049 (0%) | 0% | 90.0 | 176,074 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 89.97 per share. | 07 Jan 2020 | 4,134 | 24,708 (0%) | 0% | 90.0 | 371,941 | Common Stock |
Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 89.97 per share. | 07 Jan 2020 | 10,163 | 56,712 (0%) | 0% | 90.0 | 914,377 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 89.97 per share. | 07 Jan 2020 | 3,297 | 28,319 (0%) | 0% | 90.0 | 296,635 | Common Stock |
Kory J. Wentworth | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 89.97 per share. | 07 Jan 2020 | 223 | 6,308 (0%) | 0% | 90.0 | 20,064 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 89.97 per share. | 07 Jan 2020 | 1,049 | 18,148 (0%) | 0% | 90.0 | 94,380 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 86.66 per share. | 06 Jan 2020 | 250 | 28,842 (0%) | 0% | 86.7 | 21,665 | Common Stock |
Alison Cecily Finger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 84.96 per share. | 03 Jan 2020 | 517 | 19,197 (0%) | 0% | 85.0 | 43,924 | Common Stock |
Kory J. Wentworth | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 92.59 per share. | 19 Dec 2019 | 397 | 6,449 (0%) | 0% | 92.6 | 36,758 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2019 | 1,800 | 6,800 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 94.30 per share. | 17 Dec 2019 | 1,800 | 29,092 (0%) | 0% | 94.3 | 169,749 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. | 17 Dec 2019 | 1,800 | 30,892 (0%) | 0% | 50.5 | 90,918 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 80.57 per share. | 05 Dec 2019 | 250 | 29,092 (0%) | 0% | 80.6 | 20,143 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 81.95 per share. | 05 Nov 2019 | 250 | 29,342 (0%) | 0% | 82.0 | 20,488 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 89.07 per share. | 07 Oct 2019 | 250 | 29,592 (0%) | 0% | 89.1 | 22,267 | Common Stock |
William R. Sellers | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2019 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
William R. Sellers | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2019 | 2,000 | 2,000 (0%) | 0% | 0 | Common Stock | |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 100.11 per share. | 09 Sep 2019 | 3,000 | 31,616 (0%) | 0% | 100.1 | 300,340 | Common Stock |
David Davidson | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2019 | 2,060 | 9,625 | - | - | Stock Option (right to buy) | |
David Davidson | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2019 | 3,000 | 11,685 | - | - | Stock Option (right to buy) | |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 100.16 per share. | 09 Sep 2019 | 2,060 | 31,616 (0%) | 0% | 100.2 | 206,324 | Common Stock |
David Davidson | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. | 09 Sep 2019 | 2,060 | 33,676 (0%) | 0% | 50.5 | 104,051 | Common Stock |
David Davidson | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. | 09 Sep 2019 | 3,000 | 34,616 (0%) | 0% | 50.5 | 151,530 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 101.20 per share. | 05 Sep 2019 | 850 | 29,842 (0%) | 0% | 101.2 | 86,018 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2019 | 600 | 8,600 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. | 05 Sep 2019 | 600 | 30,692 (0%) | 0% | 50.5 | 30,306 | Common Stock |
Jeffrey T. Walsh | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 124.00 per share. | 20 Aug 2019 | 500 | 40,921 (0%) | 0% | 124 | 62,000 | Common Stock |
Jeffrey T. Walsh | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2019 | 500 | 9,521 | - | - | Stock Option (right to buy) | |
Jeffrey T. Walsh | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.47 per share. | 20 Aug 2019 | 500 | 41,421 (0%) | 0% | 24.5 | 12,235 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 124.03 per share. | 08 Aug 2019 | 950 | 30,092 (0%) | 0% | 124.0 | 117,824 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2019 | 700 | 25,000 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.60 per share. | 08 Aug 2019 | 700 | 31,042 (0%) | 0% | 75.6 | 52,920 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 118.44 per share. | 06 Aug 2019 | 400 | 31,616 (0%) | 0% | 118.4 | 47,376 | Common Stock |
David Davidson | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2019 | 5,060 | 14,685 | - | - | Stock Option (right to buy) | |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 117.77 per share. | 06 Aug 2019 | 900 | 32,016 (0%) | 0% | 117.8 | 105,995 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 116.11 per share. | 06 Aug 2019 | 800 | 32,916 (0%) | 0% | 116.1 | 92,886 | Common Stock |
David Davidson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 115.25 per share. | 06 Aug 2019 | 2,960 | 33,716 (0%) | 0% | 115.2 | 341,132 | Common Stock |
David Davidson | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. | 06 Aug 2019 | 5,060 | 36,676 (0%) | 0% | 50.5 | 255,581 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. | 05 Aug 2019 | 600 | 31,192 (0%) | 0% | 50.5 | 30,306 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2019 | 600 | 9,200 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 118.01 per share. | 05 Aug 2019 | 100 | 30,342 (0%) | 0% | 118.0 | 11,801 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 116.79 per share. | 05 Aug 2019 | 750 | 30,442 (0%) | 0% | 116.8 | 87,592 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.60 per share. | 05 Jul 2019 | 700 | 32,392 (0%) | 0% | 75.6 | 52,920 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. | 05 Jul 2019 | 600 | 31,692 (0%) | 0% | 50.5 | 30,306 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2019 | 700 | 25,700 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2019 | 600 | 9,800 | - | - | Stock Option (right to buy) | |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 131.94 per share. | 05 Jul 2019 | 100 | 30,592 (0%) | 0% | 131.9 | 13,194 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 130.69 per share. | 05 Jul 2019 | 300 | 30,692 (0%) | 0% | 130.7 | 39,207 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 129.69 per share. | 05 Jul 2019 | 311 | 30,992 (0%) | 0% | 129.7 | 40,335 | Common Stock |
Philip D. Gregory | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 128.27 per share. | 05 Jul 2019 | 1,089 | 31,303 (0%) | 0% | 128.3 | 139,690 | Common Stock |
David Davidson | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. | 05 Jul 2019 | 7,330 | 38,946 (0%) | 0% | 50.5 | 370,238 | Common Stock |